Kinsale Capital Group Inc. raised its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 50.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 28,412 shares of the biopharmaceutical company’s stock after buying an additional 9,521 shares during the period. […]